{"product_id":"penn-medicine-the-7th-alfred-p-fishman-symposium-new-scientific-discoveries-and-impact-on-patients-with-pulmonary-hypertension-or-pulmonary-embolism-2025","title":"Penn Medicine The 7th Alfred P. Fishman Symposium New Scientific Discoveries and Impact on Patients with Pulmonary Hypertension or Pulmonary Embolism 2025","description":"\u003cdiv class=\"tab-panels\"\u003e\n\u003cdiv aria-labelledby=\"tab-title-description\" class=\"woocommerce-Tabs-panel woocommerce-Tabs-panel--description panel entry-content active\" id=\"tab-description\" role=\"tabpanel\"\u003e\n\u003cdiv class=\"os-singlevideo-title os-channel-title\"\u003e\n\u003ch3\u003ePenn Medicine The 7th Alfred P. Fishman Symposium New Scientific Discoveries and Impact on Patients with Pulmonary Hypertension or Pulmonary Embolism 2025\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 18 videos + 17 pdfs, size: 6.83 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: internists, pulmonologists, cardiologists, critical care physicians\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Information:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location Friday, April 11, 2025, 8:00 AM – Saturday, April 12, 2025, 5:00 PM, The Rubenstein Auditorium at the Smilow Center for Translational Research at Penn Medicine, Philadelphia, PA\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eCourse Overview\u003c\/div\u003e\n\u003cbr\u003eThe Alfred P. Fishman Symposium will present cutting-edge topics pertinent to various types of pulmonary vascular disease. Major advances in research and understanding of the pathobiology and physiology in different types of pulmonary hypertension have translated into novel treatments for patients and a new way of looking at what constitutes successful treatment. Evolving treatment paradigms require a re-evaluation of clinical trial designs which are focused on patient well-being.\u003cbr\u003e\u003cdiv class=\"activitysectionbold\"\u003eTarget Audience\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – INTERNAL MEDICINE – Pulmonary Disease, PEDIATRICS – Pediatric Pulmonology\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eLearning Objectives\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eAfter completing this activity, participants should be able to:\u003c\/em\u003e\n\u003cbr\u003e\n\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eReview how recent scientific discoveries in pulmonary hypertension can directly translate to improved patient outcomes\u003c\/li\u003e\n\u003cli\u003eDiscuss the different types of pulmonary hypertension and the appropriate treatment for each.\u003c\/li\u003e\n\u003cli\u003eDescribe the approach to risk stratification and choice of therapies or referral for lung transplantation\u003c\/li\u003e\n\u003cli\u003eReview the new standard of care in treatment of pulmonary embolism and follow-up\u003c\/li\u003e\n\u003cli\u003eDiscuss novel and alternative approaches to studying treatments in patients with pulmonary hypertension\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cbr\u003eThe \u003cstrong\u003e7th Alfred P. Fishman Symposium: New Scientific Discoveries and Impact on Patients with Pulmonary Hypertension or Pulmonary Embolism (2025)\u003c\/strong\u003e is designed for \u003cstrong\u003ephysicians and healthcare professionals\u003c\/strong\u003e specializing in \u003cstrong\u003epulmonary vascular diseases\u003c\/strong\u003e.\u003cbr\u003e\u003cbr\u003eThis symposium is particularly beneficial for:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eInternal Medicine Physicians\u003c\/strong\u003e managing pulmonary hypertension and embolism.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003ePulmonologists \u0026amp; Pediatric Pulmonologists\u003c\/strong\u003e focusing on advanced treatment strategies.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCardiologists\u003c\/strong\u003e involved in cardiovascular aspects of pulmonary vascular disease.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCritical Care Physicians\u003c\/strong\u003e overseeing high-risk pulmonary cases.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eResearchers \u0026amp; Clinicians\u003c\/strong\u003e interested in novel therapies and evolving treatment paradigms.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003eThe event will cover \u003cstrong\u003ecutting-edge research, risk stratification, treatment approaches, and emerging therapies\u003c\/strong\u003e for pulmonary hypertension and embolism.\u003cbr\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eBPA.mp4\u003cbr\u003eBPA.pdf\u003cbr\u003eComorbidities, Inclusion Criteria, and Treatment Effects – More or Less.pdf\u003cbr\u003eConnect the Tissue Disease Dots in Pulmonary Hypertension.mp4\u003cbr\u003eConnect the Tissue Disease Dots in Pulmonary Hypertension.pdf\u003cbr\u003eData Safety and Monitoring in PAH.mp4\u003cbr\u003eData Safety and Monitoring in PAH.pdf\u003cbr\u003eHospitalized patient with PAH or IPAH- The Lung Phenotype.mp4\u003cbr\u003eHospitalized patient with PAH or IPAH- The Lung Phenotype.pdf\u003cbr\u003eMagic 8-Ball Says the Patient Has HFpEF PH.mp4\u003cbr\u003eMagic 8-Ball Says the Patient Has HFpEF PH.pdf\u003cbr\u003eMinimizing Health Care-Research Contact Days- No place like home.mp4\u003cbr\u003eMinimizing Health Care-Research Contact Days- No place like home.pdf\u003cbr\u003ePE(nn) Wars- Debate.mp4\u003cbr\u003ePE(nn) Wars- Debate.pdf\u003cbr\u003ePeople Living with Pulmonary Arterial Hypertension – In Their Own Words.mp4\u003cbr\u003eRecruiting Minority Members into PH Clinical Trials-Why and how-.mp4\u003cbr\u003eRecruiting Minority Members into PH Clinical Trials-Why and how-.pdf\u003cbr\u003eSex Healing in PAH.mp4\u003cbr\u003eSex Healing in PAH.pdf\u003cbr\u003eSlow Metabolism- The Right Ventricle in Pulmonary Hypertension.mp4\u003cbr\u003eSlow Metabolism- The Right Ventricle in Pulmonary Hypertension.pdf\u003cbr\u003eTalking to People who (may) Have a New Diagnosis of Pulmonary Hypertension.mp4\u003cbr\u003eTalking to People who (may) Have a New Diagnosis of Pulmonary Hypertension.pdf\u003cbr\u003eThe Science Leading to Sotatercept and Beyond.mp4\u003cbr\u003eThe Science Leading to Sotatercept and Beyond.pdf\u003cbr\u003eTo Transplant, or not to Transplant.mp4\u003cbr\u003eTo Transplant, or not to Transplant.pdf\u003cbr\u003eTreatment of ILD-PH – When to Hold `em and When to Fold `em.mp4\u003cbr\u003eTreatment of ILD-PH – When to Hold `em and When to Fold `em.pdf\u003cbr\u003eWelcome \u0026amp; Introduction.mp4\u003cbr\u003eWhat’s the (End) Point-.mp4\u003cbr\u003eWhat’s the (End) Point-.pdf\u003cbr\u003eWSPH Treatment Algo in Pulmonary Hypertension.mp4\u003cbr\u003eWSPH Treatment Algo in Pulmonary Hypertension.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954490871906,"sku":"MED-AMB04444","price":50.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Penn-Medicine-The-7th-Alfred-P.-Fishman-Symposium-New-Scientific-Discoveries-and-Impact-on-Patients-with-Pulmonary-Hypertension-or-Pulmonary-Embolism-2025.jpg?v=1779377869","url":"https:\/\/meducourse.com\/products\/penn-medicine-the-7th-alfred-p-fishman-symposium-new-scientific-discoveries-and-impact-on-patients-with-pulmonary-hypertension-or-pulmonary-embolism-2025","provider":"Meducourse","version":"1.0","type":"link"}